ASG-5ME: Clinical Trials

2 trials of ASG-5ME, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow ASG-5ME: new trials by email Literature Review of ASG-5ME trials Research Report on ASG-5ME

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
ASG-5ME - Prostate Neoplasms
Phase 1CompletedAstellas Pharma Inc462010-10-012013-06-07
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
ASG-5ME - Gastric Neoplasms, Pancreatic Neoplasms
Phase 1CompletedSeagen Inc.512010-07-012013-08-27

Conditions studied

Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Stomach Neoplasms (1)

Sponsors

Astellas Pharma Inc (1)  ·  Seagen Inc. (1)

Countries

United States (2)

Top investigators

Nancy Whiting, PharmD, BCOP (1)